Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAREMETAL Resource Report Resource Website 10+ mentions |
RAREMETAL (RRID:SCR_003573) | RAREMETAL | software resource | A software program that facilitates the meta-analysis of rare variants from genotype arrays or sequencing. | bio.tools |
is listed by: OMICtools is listed by: bio.tools is listed by: Debian has parent organization: University of Michigan; Ann Arbor; USA |
PMID:24894501 | biotools:raremetal, OMICS_00243 | https://bio.tools/raremetal | SCR_003573 | 2026-07-25 12:05:41 | 22 | |||||||
|
Myelin Repair Foundation Resource Report Resource Website 1+ mentions |
Myelin Repair Foundation (RRID:SCR_003723) | MRF | institution | A non-profit foundation that funds basic research and is focused on accelerating the development of myelin repair therapeutics for multiple sclerosis. They have defined a 15-year research plan to develop a drug or drugs and believes its Accelerated Research Collaborative (ARC) model can subsequently be used to accelerate the treatment for all diseases. The ARC framework coordinates and manages the entire therapeutic development continuum from discovery biology to FDA approval. The model works by coordinating multi-disciplinary basic research from academic and government laboratories, systematically validating and derisking potential compounds/targets, and collaborating with pharma partners to increase the probability of successful programs. | consortium, drug, myelin repair, therapeutic, myelin, drug development | is listed by: Consortia-pedia | Multiple Sclerosis, Neurological disease | nlx_157901, grid.429475.9, Wikidata: Q6947290 | https://ror.org/05yb6xa82 | SCR_003723 | 2026-07-25 12:05:43 | 3 | |||||||
|
Tocris Bioscience Resource Report Resource Website 100+ mentions |
Tocris Bioscience (RRID:SCR_003689) | commercial organization | An Antibody supplier | nlx_152479 | SCR_003689 | 2026-07-25 12:05:42 | 387 | ||||||||||||
|
TransCelerate BioPharma Resource Report Resource Website 1+ mentions |
TransCelerate BioPharma (RRID:SCR_003728) | TransCelerate | nonprofit organization | Non-profit research organization aiming to accelerate drug development by increasing the quality and efficiency of clinical studies through the development of shared tools, methods, and platforms. Consortium partnerships are limited to pharmaceutical and biotechnology companies with research & development operations, although there are collaborations with external organizations such the Clinical Data Interchange Standards Consortium (CDISC). Its current focus is to collaborate on: * Standardizing risk-based monitoring * Development of methods to qualify and train clinical trial sites * Development of a common investigator web portal * Development of clinical data standards on efficacy, and methods for comparator drug trials It currently has 5 projects: # Standardized Approach for High-Quality, Risk-Based Monitoring program aims to develop an industry-wide standard and approach for risk-based monitoring of clinical trials in order to enhance patient safety and ensure the quality of clinical trial data. # Shared Site Qualification and Training program aims to standardize GCP training and site qualification credentials in order to realize efficiencies and accelerate study start-up timelines. # Common Investigator Site Portal is a platform designed to streamline investigator and site access through harmonized delivery of content and services. # Data Standards project is a partnership with CDISC to develop industry-wide data standards in priority therapeutic areas to support the exchange and submission of clinical research and meta-data, improving patient safety and outcomes. # Comparator Drugs project aims to establish reliable, rapid sourcing of quality products for use in clinical trials through a comparator supply model enabling accelerated trial timelines and enhanced patient safety. | drug, clinical trial, multipharma, data sharing, drug development, consortium, medicine, clinical, standard specification | is listed by: Consortia-pedia | Member companies financial contributions ; Member companies in-kind contributions ; GlaxoSmithKline |
nlx_157913 | SCR_003728 | TransCelerate BioPharma Inc. | 2026-07-25 12:05:42 | 4 | |||||||
|
Roslin Cells Resource Report Resource Website 1+ mentions |
Roslin Cells (RRID:SCR_003857) | Roslin Cells | commercial organization | Organization that supplies undifferentiated, clinical grade, human pluripotent stem cell lines to the life science community, and works with academic, clinical and commercial colleagues to enable and facilitate the use of these high grade cells in the development of new reagents, drugs and cellular therapeutics. They also seek to drive the economic development of the stem cell sector in Scotland. Their products can act as a valuable tool in supporting clients' drug discovery, development and clinical research programmes. | pluripotent stem cell, induced pluripotent stem cell, cell therapy, embryonic stem cell line, clinical grade |
is listed by: One Mind Biospecimen Bank Listing is parent organization of: EBiSC |
nlx_158181 | SCR_003857 | Roslin Cells Ltd | 2026-07-25 12:05:43 | 2 | ||||||||
|
PEAR Resource Report Resource Website 500+ mentions |
PEAR (RRID:SCR_003776) | PEAR | software resource | Software for an ultrafast, memory-efficient and highly accurate pair-end read merger. It is fully parallelized and can run with as low as just a few kilobytes of memory. | next-generation sequencing, sequence analysis |
is listed by: OMICtools has parent organization: Heidelberg Institute for Theoretical Studies; Heidelberg; Germany |
PMID:24142950 | OMICS_00674 | SCR_003776 | Pair-end read merger, PEAR: Pair-end read merger | 2026-07-25 12:05:42 | 854 | |||||||
|
Chevron Corporation Resource Report Resource Website 1+ mentions |
Chevron Corporation (RRID:SCR_003794) | Chevron, CVX | commercial organization | An American multinational energy corporation headquartered in San Ramon, California, and active in more than 180 countries, that is engaged in every aspect of the oil, gas, and geothermal energy industries, including exploration and production; refining, marketing and transport; chemicals manufacturing and sales; and power generation. Chevron is one of the world's largest oil companies; as of 2013, it ranked third in the Fortune Global 500-2014 list of the world's largest companies. (Adapted from Wikipedia) | oil, gas, geothermal energy, chemicals manufacturing, power generation | Crossref funder ID: 100004366, grid.450626.3, ISNI: 0000 0004 0599 8199, Wikidata: Q319642, nlx_158090 | https://ror.org/02jfa8730 | SCR_003794 | Chevron Corp., Chevron Corp | 2026-07-25 12:05:44 | 1 | ||||||||
|
BioReliance Resource Report Resource Website 50+ mentions |
BioReliance (RRID:SCR_003791) | BREL | commercial organization | Company that provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies that span the product cycle from early pre-clinical development to licensed production. | testing, manufacturing, pharmaceutical, biopharmaceutical |
has parent organization: Sigma-Aldrich is parent organization of: BioReliance Biorepository |
nlx_158085 | SCR_003791 | BioReliance Corporation, BioReliance Corp. | 2026-07-25 12:05:44 | 62 | ||||||||
|
Selleck Chemicals LLC Resource Report Resource Website 100+ mentions |
Selleck Chemicals LLC (RRID:SCR_003823) | commercial organization | An Antibody supplier | antibody, chemical supply, selleck chemicals | nlx_152457 | SCR_003823 | Selleck Chemicals | 2026-07-25 12:05:43 | 192 | ||||||||||
|
BioClinica Resource Report Resource Website 100+ mentions |
BioClinica (RRID:SCR_003789) | BioClinica | commercial organization | Pennsylvania-based company supporting pharmaceutical and medical device innovation with imaging core lab, EDC, IVR / IWR, CTMS, and supply chain forecasting and optimization. Its initial service was medical imaging for clinical trials. It is used to capture, collect, control quality, provide blinded reading services to the final delivery to the sponsor company and to the FDA or EMEA if required for medical images in a wide range of imaging modalities. (Wikipedia) | clinical trial, pharmaceutical, medical device, medical imaging, cardiac safety, clinical | Crossref funder ID: 100007742, ISNI: 0000 0004 0602 1531, Wikidata: Q4914605, grid.430790.9, nlx_158082 | https://ror.org/03t95yr58 | SCR_003789 | BioClinica Inc. | 2026-07-25 12:05:42 | 101 | ||||||||
|
Quretec Resource Report Resource Website 1+ mentions |
Quretec (RRID:SCR_003826) | Quretec | commercial organization | Commercial organization that builds software for collection, management, and analysis of complex data, most typical in biomedical domain. The solutions are generic and can be used for multitude of uses and application domains. | data capture, data management, analysis, biomedical | is related to: AgedBrainSYSBIO | grid.436973.c, Wikidata: Q30291134, nlx_158133 | https://ror.org/02ca38p84 | SCR_003826 | Quretec Ltd., Quretec Ltd | 2026-07-25 12:05:43 | 2 | |||||||
|
Onyx Pharmaceuticals Resource Report Resource Website 1+ mentions |
Onyx Pharmaceuticals (RRID:SCR_003782) | Onyx, ONXX | commercial organization | November 2020, Onyx merged with Legacy Acquisition Corp. to form PARTS iD, Inc. Our data intelligence, integrated platforms, product cataloging, digital marketing expertise, and virtual warehousing have ensured our continued leadership in the competitive marketplace. | drug, pharmaceutical, biotechnology | nlx_158070 | https://www.biospace.com/employer/540942/onyx-pharmaceuticals-inc-/ | SCR_003782 | Onyx Pharmaceuticals Inc. | 2026-07-25 12:05:44 | 5 | ||||||||
|
European Federation of Pharmaceutical Industries and Associations Resource Report Resource Website 10+ mentions |
European Federation of Pharmaceutical Industries and Associations (RRID:SCR_003820) | EFPIA | institution | Federation representing the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, it is the voice on the EU scene of 1,900 companies committed to researching, developing and manufacturing new medical treatments. In addition, it is active in partnering in EU Research programmes, such as the IMI (Innovative Medicines Initiative), Europe's largest public-private partnerships. They also work on corporate social responsibility initiatives with others healthcare stakeholders, such as patient groups and healthcare professionals. EFPIA has specialized committees and task forces focused on key areas of activity. EFPIA also includes two specialized groups focusing on vaccines and biotechnology, respectively: * Vaccines Europe (formerly European Vaccine Manufacturers, EVM) produces approximately 80% of vaccines used worldwide * European Biopharmaceutical Enterprises (EBE) harness biotechnology to develop approximately one-fifth of new medicines | pharmaceutical, medicine, vaccine, biotechnology, manufacturing, corporate |
is affiliated with: Merck is affiliated with: Roche is related to: Innovative Medicines Initiative is parent organization of: Innovative Medicines Initiative |
nlx_158124, grid.484123.8, ISNI: 0000 0000 9246 8110, Wikidata: Q1376562 | https://ror.org/00g1x4v36 | SCR_003820 | 2026-07-25 12:05:43 | 12 | ||||||||
|
Olink Bioscience Resource Report Resource Website 100+ mentions |
Olink Bioscience (RRID:SCR_003899) | Olink | commercial organization | Commercial organization that produces products for biomarker research and development. Their goal is to help customers and collaborators to improve clinical decisions through the use of molecular biomarkers. Their tools bring new insights into disease processes, improve disease detection, and contribute to a better understanding of biology. | biomarker, disease | is related to: READNA | nlx_158232 | SCR_003899 | 2026-07-25 12:05:45 | 262 | |||||||||
|
Asthma UK Resource Report Resource Website 10+ mentions |
Asthma UK (RRID:SCR_003815) | Asthma UK | institution | Charity that aims to significantly reduce the number of asthma deaths, hospitalizations and living lives compromised by asthma helping over five million people with asthma in the UK through research, campaigning, health promotion and engagement with the asthma community. Asthma UK is a significant investor in asthma research within the UK and to date has invested over 50 million pounds into research for better treatments and ultimately a cure for asthma. | lung, treatment | is parent organization of: EARIP | Asthma | Crossref funder ID: 501100000362, ISNI: 0000 0000 9981 854X, nlx_158172, grid.453156.0 | https://ror.org/03z7xev21 | SCR_003815 | 2026-07-25 12:05:42 | 12 | |||||||
|
EURORDIS Resource Report Resource Website 10+ mentions |
EURORDIS (RRID:SCR_003814) | EURORDIS | nonprofit organization | EURORDIS is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, dedicated to improving the quality of life of all people living with rare diseases in Europe. It is a not-for-profit organization and represents more than 479 rare disease organizations in 45 different countries (of which 25 are EU Member States), covering more than 4,000 rare diseases. It is therefore the voice of the 30 million patients affected by rare diseases throughout Europe. EURORDIS aims at improving the quality of life of people living with rare diseases in Europe through advocacy at the European level, support for research and drug development, networking patient groups, raising awareness and other actions designed to fight against the impact of rare diseases on the lives of patients and family. EURORDIS' training programs and resources are designed to strengthen the capacity of rare disease patients' representatives. Training empowers patients' representatives to advocate effectively for rare diseases at both the local and EU level. Key issues affecting patients of Rare Diseases on which we actively work: * Sustaining rare diseases as an EU public health priority * Making Rare Diseases A Public Health Priority In All Member States * Rare Diseases: An International Public Health Priority * Improving Access To Orphan Drugs * Improving Access To Quality Care * Promoting cross-border healthcare and patient mobility * Bridging Patients And Research * Genetic testing and newborn screening | French Muscular Dystrophy Association ; European Union ; members ; corporate foundations ; health industry |
Wikidata: Q5412882, grid.433753.5, nlx_143535 | https://ror.org/019w4mg02 | SCR_003814 | EURORDIS - Rare Diseases Europe | 2026-07-25 12:05:44 | 38 | ||||||||
|
Alzheimer's Research UK Resource Report Resource Website 10+ mentions |
Alzheimer's Research UK (RRID:SCR_003847) | ARUK | nonprofit organization | The UK's leading dementia research charity that funds world-class, pioneering scientists at leading universities to find preventions, treatments and a cure for dementia. | late adult human, treat, prevent, alzheimer, dementia, portal, funding resource | Alzheimer's disease, Dementia | ISNI: 0000 0000 9689 1581, Crossref funder ID: 501100002283, Wikidata: Q2840694, nlx_158161, grid.453466.6 | https://ror.org/02ymzm013 | SCR_003847 | Alzheimers Research UK | 2026-07-25 12:05:43 | 15 | |||||||
|
Nephropath Resource Report Resource Website 1+ mentions |
Nephropath (RRID:SCR_003995) | Nephropath | commercial organization | Commercial service interpreting renal biopsies using 14 board-certified, fellowship-trained pathologists with decades of experience. They provide doctors with a high quality, clinico-pathologic discussion by the pathologist that read the case. It is their goal to help equip doctors with the results they need to deliver the most effective patient care possible. That is why they deliver same-day biopsy results, including EM, because they know that time often has a critical effect on the outcome of many renal diseases. Nephropath also offers PLA2R serum testing and will soon be offering neuropathology services including muscle and nerve biopsy services.Nephropath is now Arkana Laboratories. | pathology, neuropathology, muscle, nerve, biopsy service, pathologist, kidney, biopsy, renal, serum, neurology | is related to: Kidney Health Initiative | Kidney disease | nlx_158408 | SCR_003995 | 2026-07-25 12:05:45 | 1 | ||||||||
|
Janssen Research and Development Resource Report Resource Website 1+ mentions |
Janssen Research and Development (RRID:SCR_003904) | Janssen R&D | commercial organization | Pharmaceutical company with a mission to discover and develop innovative medicines that ease patients'' suffering, and solve the most important unmet medical needs of our time. As one of the Janssen Pharmaceutical Companies, their strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. They leverage their world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, and oncology. | pharmaceutical, oncology, immunology, neuroscience, vaccine, medical |
is related to: Investigator Databank is related to: eTRIKS is related to: Predict-TB is related to: OncoTrack is related to: European Lead Factory is related to: EU-AIMS is related to: GetReal is related to: Kinetics for Drug Discovery is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PharmaCog is related to: PREDECT is related to: Structural Genomics Consortium is related to: Open PHACTS is related to: EMIF is parent organization of: Investigator Databank |
Infectious disease, Cardiovascular disease, Metabolic disease, Immunological disorder, Cancer | nlx_158241 | SCR_003904 | Janssen Research & Development LLC, Janssen Research & Development | 2026-07-25 12:05:44 | 2 | |||||||
|
FlexGen Resource Report Resource Website 1+ mentions |
FlexGen (RRID:SCR_003902) | FlexGen | commercial organization | A biotechnology company that has developed technology for synthesizing custom microarrays, the FlexArrayer. Its is a desk-top sized instrument which allows the researcher to generate, in their own laboratory, either a custom oligonucleotide array in a single day or oligonucleotide pool in a few days. Recent developments in synthesis chemistry allows many modifications to be incorporated or for alternative chemistries to be considered., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biotechnology, microarray, custom oligonucleotide array, oligonucleotide pool, oligonucleotide, gene, probe synthesis, target enrichment, probe design, biomolecule, dna sequencing, oligonucleotide synthesis, re-sequencing | is related to: READNA | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158237 | SCR_003902 | FlexGen B.V. | 2026-07-25 12:05:45 | 6 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the PRECISE-TBI Resources search. From here you can search through a compilation of resources used by PRECISE-TBI and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that PRECISE-TBI has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on PRECISE-TBI then you can log in from here to get additional features in PRECISE-TBI such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into PRECISE-TBI you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
